Genetic alterations in TERT can be due to TERTp mutations (54% of cases), TERT focal amplification (6.7%), or HBV genome integration into the TERT promoter (22% of HBV-related HCC) [7]. This evidence concerns the gene TERT and hepatocellular carcinoma.